Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 1.00 |
| ▸ | CYP2C8 | P10632 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 3/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.98 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.98 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.98 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gingerol SCHEMBL17368634 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL32102 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL30767163 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL29475335 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL17301613 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL20668234 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL17301612 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL20668179 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL4883453 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL4885722 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119522938-A | Zingiberaceae plant extract, composition thereof and pest control application thereof | 成都新朝阳作物科学股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-113040147-B | High-safety synergistic disinfectant for livestock | 江苏康巴特生物工程有限公司 | 2022-02-11 | — | — | CN | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-20150119327-A1 | DRUG SCREENING PLATFORM FOR RETT SYNDROME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-04-30 | — | — | US | claimed |
| EP-2841067-A2 | A DRUG SCREENING PLATFORM FOR RETT SYNDROME | The Regents of The University of California (US) | 2015-03-04 | — | — | EP | claimed |
| WO-2013163455-A2 | A DRUG SCREENING PLATFORM FOR RETT SYNDROME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-10-31 | — | — | WO | claimed |
| EP-2578222-A1 | Plant extract composition | Lanwehr, Christoph Alexander Bernhard (DE) | 2013-04-10 | — | — | EP | claimed |
| WO-2008080980-A1 | MEDICINAL COMPOSITION FOR TREATING ANIMAL SKIN COMPRISING A WOUND HEALING AGENT AND A DETERRENT | FRANKE PATRICK (DE) | 2008-07-10 | — | — | WO | claimed |
| JP-9176002-A | — | — | None | — | — | JP | disclosed |
| US-12588699-B2 | Aerosol-generating substrate | PHILIP MORRIS PRODUCTS S.A. (CH) | 2026-03-31 | — | — | US | disclosed |
| EP-4665315-A1 | METHODS OF PREPARATION OF ZINGERONE, COMPOSITIONS COMPRISING ZINGERONE, AND USES THEREFOR | Evithe Limited (NZ) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255927-A1 | COMPOSITIONS AND METHODS FOR ALLEVIATING ADVERSE EFFECTS FROM RESPONSIBLE ALCOHOL CONSUMPTION | CHEERS HEALTH, INC. | 2025-08-14 | — | — | US | disclosed |
| WO-2000002569-A2 | COMPOSITIONS FOR THE TREATMENT OF ATHEROSCLEROSIS AND RELATED CONDITIONS | DALIDAR PHARMA ISRAEL (1995) LTD. (IL) | 2000-01-20 | — | — | WO | disclosed |
| EP-0631474-B1 | CYCLIC ANTI-TUMOR PROMOTER COMPOUNDS, COMPOSITIONS AND METHODS FOR PRODUCTION AND USE | UNIV HAWAII (US) | 1998-12-23 | — | — | EP | disclosed |
| JP-H09176002-A | GINGEROL-CONTAINING AGENT FOR SUPPRESSING SYNTHESIS OF PROTEIN OF HSP27 FAMILY | KUREHA CHEM IND CO LTD | 1997-07-08 | — | — | JP | disclosed |
| US-5349112-A | Cyclic anti-tumor promoter compounds, compositions and methods for production and use | UNIVERSITY OF HAWAII (US) | 1994-09-20 | — | — | US | disclosed |
| US-5276217-A | Anticarcinogenic, analog of sarcophytol A, carbocyclic compound with 6-14 ring carbons | UNIVERSITY OF HAWAII (US) | 1994-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | LTA4H 753/4885CYP3A4 3571/4885TRPV1 1110/4885 |
| US-20150119327-A1 | DRUG SCREENING PLATFORM FOR RETT SYNDROME | GRIN2A, GRIN1, GRIN2B | LTA4H 3911/4885CYP3A4 4856/4885TRPV1 1320/4885 |
| US-12588699-B2 | Aerosol-generating substrate | CCT5, PRUNE1, DSTN | LTA4H 3290/4885CYP3A4 1241/4885TRPV1 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.